Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	73.65	41.25	36.6	50.31	24.94
Short-Term Investments	157.79	698.44	458.25	415.55	495.14
Cash & Short-Term Investments	231.43	739.69	494.84	465.86	520.07
Cash Growth	-68.71%	49.48%	6.22%	-10.42%	-4.67%
Accounts Receivable	207.35	194.75	169.62	152.07	140.01
Other Receivables	11	50.02	42.28	21.31	43.02
Receivables	218.87	245.67	213.08	175.28	184.14
Inventory	88.8	85.66	83.38	98.98	76.17
Prepaid Expenses	11.59	6.77	4.59	5.53	4.36
Other Current Assets	14.61	19.49	15.02	13.39	15.13
Total Current Assets	565.32	1,097	810.91	759.04	799.87
Property, Plant & Equipment	547.06	112.14	112.19	113.05	104.47
Long-Term Investments	767.44	173.9	344.09	415.71	209.79
Goodwill	-	-	-	-	0.01
Other Intangible Assets	2.28	3.88	1.87	3.06	4.8
Long-Term Deferred Tax Assets	14.69	7.98	4.25	3.71	7.37
Other Long-Term Assets	64.89	255.51	144.23	133.59	84.71
Total Assets	1,962	1,651	1,418	1,429	1,212
Accounts Payable	81.55	62.57	60.97	71.1	45.92
Accrued Expenses	16.04	9.31	2.55	2.59	12.73
Short-Term Debt	19.79	-	24.39	58.15	37.11
Current Portion of Leases	4.23	-	4.89	4.51	4.17
Current Income Taxes Payable	2.86	16.41	3.37	0.77	2
Other Current Liabilities	63.72	75.49	61.46	75.67	78
Total Current Liabilities	188.19	163.79	157.62	212.8	179.92
Long-Term Leases	14.92	-	-	4.89	9.4
Long-Term Deferred Tax Liabilities	10.87	7.9	7.18	8.56	8.21
Other Long-Term Liabilities	30.1	29.91	29.43	29.43	29.65
Total Liabilities	244.09	201.59	194.22	255.67	227.17
Common Stock	44.13	44.13	44.13	45.89	45.89
Retained Earnings	1,657	1,375	1,165	1,119	942.57
Comprehensive Income & Other	16.76	30.62	15.25	9.2	-3.8
Shareholders' Equity	1,718	1,449	1,224	1,174	984.66
Total Liabilities & Equity	1,962	1,651	1,418	1,429	1,212
Total Debt	38.94	-	29.28	67.55	50.67
Net Cash (Debt)	192.5	739.69	465.57	398.31	469.4
Net Cash Growth	-73.98%	58.88%	16.89%	-15.15%	-4.92%
Net Cash Per Share	43.62	167.61	101.97	86.79	102.28
Filing Date Shares Outstanding	4.41	4.41	4.41	4.59	4.59
Total Common Shares Outstanding	4.41	4.41	4.41	4.59	4.59
Working Capital	377.12	933.49	653.29	546.24	619.95
Book Value Per Share	389.23	328.42	277.32	255.77	214.55
Tangible Book Value	1,715	1,446	1,222	1,171	979.85
Tangible Book Value Per Share	388.71	327.54	276.90	255.10	213.50
Buildings	117.96	107.24	103.86	101.39	96.73
Machinery	237.32	206.45	193.64	191.2	178.46
Construction In Progress	402.77	12.41	9.57	2.12	3.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.